Robert Naclerio to Anti-Allergic Agents
This is a "connection" page, showing publications Robert Naclerio has written about Anti-Allergic Agents.
Connection Strength
3.509
-
Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
Score: 0.453
-
Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
Score: 0.389
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.376
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.343
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.316
-
Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
Score: 0.298
-
Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol. 2002; 17:101-39.
Score: 0.206
-
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
Score: 0.194
-
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
Score: 0.183
-
Antiallergic effects of H1-receptor antagonists. Allergy. 2000; 55 Suppl 64:17-27.
Score: 0.179
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
Score: 0.170
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.098
-
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
Score: 0.096
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.079
-
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
Score: 0.059
-
Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
Score: 0.051
-
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006 Sep; 61(9):1086-96.
Score: 0.018